These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 883399)

  • 1. [State of some immunological indices in patients with lupus erythematosus and scleroderma].
    Nesterenko GB; Didenko IG
    Vestn Dermatol Venerol; 1977 Jun; (6):16-9. PubMed ID: 883399
    [No Abstract]   [Full Text] [Related]  

  • 2. [Humoral and cellular immunity indices in lupus erythematosus and scleroderma].
    Butov IuS; Skripkin IuK; Koshevenko IuN
    Vestn Dermatol Venerol; 1978 Apr; (4):7-11. PubMed ID: 77599
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autoimmune and autoaggressive diseases].
    Spier HW
    Arch Klin Exp Dermatol; 1970; 237(1):18-26. PubMed ID: 5417105
    [No Abstract]   [Full Text] [Related]  

  • 4. Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease.
    Whicher JT; Gilbert AM; Westacott C; Hutton C; Dieppe PA
    Clin Exp Immunol; 1986 Jul; 65(1):80-9. PubMed ID: 3491701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-immunologic parallels in patients with lupus erythematosus and scleroderma].
    Skripkin JK; Somov BA; Butov JS; Bereshnoj JZ
    Allerg Immunol (Leipz); 1972; 18(3):163-6. PubMed ID: 4269348
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological reactions to connective tissue antigens in rheumatoid arthritis, systemic scleroderma and systemic lupus erythematosus].
    Abdeeva ZhI; Zakharova MM; Rassokhina II; Trofimova TM; Samoĭlova SI
    Ter Arkh; 1980; 52(11):122-6. PubMed ID: 7466639
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blastic lymphocyte transformation in lupus erythematosus and scleroderma].
    Pawińska M; Gliński W; Blaszczyk M; Wranicz A
    Przegl Dermatol; 1973; 60(2):161-6. PubMed ID: 4134109
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cellular immunity in lupus erythematosus and scleroderma].
    Gliński W; Langner A; Pawińska M
    Przegl Dermatol; 1976; (6 Suppl):329-34. PubMed ID: 1032181
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. II. Reactivity with hsa-coupled, uridine-containing, monophosphoric ribodinucleotides.
    Alarcón-Segovia D; Fishbein E; Estrada-Parra S; García-Ortigoza E
    Immunology; 1976 Mar; 30(3):413-8. PubMed ID: 1082854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoallergic indicators and blood vessel permeability in systemic lupus erythematosus and scleroderma].
    Nesterenko GB; Didenko IG
    Vrach Delo; 1978 Feb; (2):99-102. PubMed ID: 645012
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cellular and humoral factors of immunogenesis of sytemic lupus erythematosus and systemic scleroderma].
    Demin AA; Galenok VA; Kolesnuk VV; Finchenko AF
    Klin Med (Mosk); 1973 Nov; 51(11):100-4. PubMed ID: 4787290
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intradermoreaction to autoplatelets in rheumatoid arthritis. Preliminary research].
    Pannuti F; Masiello O
    Arch Patol Clin Med; 1967 Mar; 43(3):185-206. PubMed ID: 5606709
    [No Abstract]   [Full Text] [Related]  

  • 14. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 15. Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease.
    Parker MD
    J Lab Clin Med; 1973 Nov; 82(5):769-75. PubMed ID: 4583583
    [No Abstract]   [Full Text] [Related]  

  • 16. [DNA-antibodies in patients with lupus erythematosus, scleroderma and blister-forming skin diseases].
    Kerl H; Sandhofer M; Klein G; Altmann H
    Hautarzt; 1975 Jan; 26(1):30-4. PubMed ID: 1090563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of circulating immunoblasts in the peripheral blood of patients with systemic lupus erythematosus and other rheumatic diseases].
    Bulanova TD; le Go A; Alekberova ZS; Polianskaia IP
    Ter Arkh; 1980; 52(6):64-7. PubMed ID: 6967635
    [No Abstract]   [Full Text] [Related]  

  • 18. [Abnormal HLA-DR antigen expression in monocytes of patients with systemic lupus erythematosus and psoriasis vulgaris].
    Volk HD; Diezel W; Waschke SR; Barthelmes H; Grunow R; Fiebig H; Sönnichsen N
    Dermatol Monatsschr; 1985; 171(5):308-11. PubMed ID: 3926547
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease models of autoimmunity.
    Ferguson CA
    Trends Immunol; 2005 Nov; 26(11):557-8. PubMed ID: 16182605
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.